The company said Sept. 27 that CEO John Standley will remain chief executive; however, he will no longer also hold the title of chairman. Instead, current director Bruce Bodaken will become chairman.
In addition, Rite Aid nominated three new directors — Robert Knowling, Louis Miramontes and Arun Nayar — to its board. Shareholders will vote on the changes in October.
Rite Aid accelerated the board shake-up after speaking with shareholders after it abandoned its merger with grocery store chain Albertsons. Investors opposed the planned merger because it would have facilitated Albertsons’ private equity owner to take the company public without rewarding Rite Aid shareholders.
The failed Albertsons deal followed another proposed buyout from Walgreens, which also collapsed.
Rite Aid is attempting to fend off larger rivals such as Amazon and CVS.
More articles on pharmacy:
PBM lobby selects new chief with government ties: 5 things to know
AbbVie hit with lawsuit over alleged $1.2B kickback scheme
Reputation save: Novartis links employee bonuses to ethical behavior
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
